IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Knoll Capital Management, LLC

Q4 2016 Holdings

Filed 2017-02-14 | 17 holdings | $3.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Anavex Life Sciences Corp(AVXL)COM NEW032797300$2.9M724,20578.6%
Aldeyra Therapeutics Inc(ALDX)COM01438T106$727.0K135,80019.9%
Corbus Pharmaceuticals Hldgs(CRBPEUR)COM21833P103$21.7K2,563,9250.6%
Abeona Therapeutics Inc(ABEO1EUR)COM00289Y107$11.4K2,359,7670.3%
Vascular Biogenics LTDCOMM96883109$4.2K860,6050.1%
Ritter Pharmaceuticals, IncCOM767836109$2.6K952,4340.1%
Alcobra LtdSHSM2239P109$2.5K1,205,4980.1%
Ampio Pharmaceuticals Inc.COM03209T109$2.5K2,738,3220.1%
Volition RX LTD(VNRX)COM928661107$2.1K461,5380.1%
Advaxis Inc.COM NEW007624208$1.6K225,0000.0%
Synthetic Biologics Inc.COM87164U102$1.6K2,034,9490.0%
Keryx Biopharmaceuticals Inc.COM492515101$1.2K200,0000.0%
Newlink Genetics CorpCOM651511107$96293,5330.0%
Advaxis Inc.W EXP 07/15/201007624117$446112,5000.0%
OHR Pharmaceutical IncCOM NEW67778H200$306204,1370.0%
Bio Blast Pharma LtdSHSM20156101$214206,0540.0%
Caladrius Biosciences Inc(NBSEUR)COM NEW128058203$15755,5790.0%